# John Bates

> John Bates is a seed investor at Enterprise 100 backing Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Enterprise 100](https://shizune.co/investors/profile/enterprise-100)
- Total investments: 1
- Last investment: Jun 2022
- Lead investor: 100%
- Last updated: Aug 2026

John Bates is a seed investor at Enterprise 100 focused on Biotechnology. John Bates is the member at Enterprise 100 Club.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Sonichem | Biorefinery technology to separate non-food waste lignocellulosic biomass into high-value biochemicals | $1.7M | Seed | Jun 22, 2022 |  |

1 of 1 investments shown.

## Co-investors
- [ACF Investors](https://shizune.co/investors/profile/angel-cofund) — VC Fund, 1 deal together

## About Enterprise 100

VC Fund · London, United Kingdom

Enterprise 100 ('E100') is an exceptional angel network based at London Business School since 1999 and intricately connected with this world-leading business school. Nominated as Best Angel Network by Investor AllStars (2012), Enterprise 100 is recognised as one of the leading business angel groups in the UK. E100 charges no feesfor companies to pitch for money at their quarterly meetings, and no fees are charged nor equity taken for money raised from the members. Integral to the value that E100 provides its members, companies which pitch at E100 events must not have presented to other angel networks for that round of funding before appearing at E100. Members who are planning to make an investment in an angel round can circulate opportunities to other members between meetings. All applications for membership are screened to maintain the unrivalled quality of E100's membership from which intermediaries are excluded, providing the valuable atmosphere envisaged by the founders of ' a club for like-minded people to come together and invest in early stage businesses'.

3 contacts available at Enterprise 100.

| Name | Title | Profile |
| --- | --- | --- |
| John Bates | Member | https://shizune.co/investors/profile/john-bates-7bf6 |
| Michael Bristow | Member | https://shizune.co/investors/profile/mike-bristow |
| Robert Nichols | Member - Angel Investor | https://shizune.co/investors/profile/robert-nichols-b9cc |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does John Bates invest in?

John Bates invests primarily in Biotechnology startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did John Bates last invest?

The most recent investment recorded for John Bates closed in Jun 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co